SAFETY, TOLERANCE, AND PHARMACOKINETICS OF XANOMELINE TARTRATE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY ELDERLY SUBJECTS

被引：0
|
作者：
SATTERWHITE, JH
LUCAS, RA
HEATON, J
CARTER, GV
机构：
[1] ELI LILLY & CO,LILLY LAB CLIN RES,INDIANAPOLIS,IN 46202
[2] LILLY RES CTR LTD,WINDLESHAM GU20 6PH,SURREY,ENGLAND
来源：
NEUROBIOLOGY OF AGING | 1994年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] SINGLE AND MULTIPLE-DOSE SAFETY, PHARMACODYNAMICS AND PHARMACOKINETICS OF XANOMELINE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY MALE-SUBJECTS
    BODICK, NC
    SATTERWHITE, JH
    LUCAS, RA
    HEATON, J
    CARTER, GV
    NEUROBIOLOGY OF AGING, 1994, 15 : S104 - S105
  • [2] Persistent receptor activation by the M1 muscarinic agonist, xanomeline
    El-Fakahany, EE
    Christopoulos, A
    Pierce, TL
    Sorman, JL
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 32S - 32S
  • [3] XANOMELINE - A POTENT AND SELECTIVE M1 MUSCARINIC AGONIST IN-VITRO
    MITCH, CH
    BYMASTER, FP
    CALLIGARO, DO
    QUIMBY, SJ
    SAWYER, BD
    SHANNON, HE
    WARD, JS
    OLESEN, PH
    SAUERBERG, P
    SHEARDOWN, MJ
    SUZDAK, PD
    NEUROBIOLOGY OF AGING, 1994, 15 : S104 - S104
  • [4] THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE, A M(1)-SPECIFIC CHOLINERGIC AGONIST, IN PATIENTS WITH ALZHEIMERS-DISEASE
    SRAMEK, JJ
    CUTLER, NR
    SEIFERT, RD
    CONRAD, JJ
    WARDLE, TS
    HURLEY, DJ
    THOREN, LM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 174 - 174
  • [5] Allosteric muscarinic M1 receptor action of hybrids related to the M1 agonist xanomeline and to tacrine
    Jumpertz, S.
    Fang, L.
    Decker, M.
    Zhang, Y.
    Mohr, K.
    Traenkle, C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 15 - 15
  • [6] The M1 muscarinic acetylcholine receptor agonist xanomeline suppresses lethal inflammation
    Pavlov, Valentin A.
    Ochani, Mahendar
    Ochani, Kanta
    Rosas-Ballina, Mauricio
    Al-Abed, Yousef
    Tracey, Kevin J.
    FASEB JOURNAL, 2009, 23
  • [7] THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE, AN M1-SPECIFIC CHOLINERGIC AGONIST, IN PATIENTS WITH ALZHEIMERS-DISEASE
    CUTLER, NR
    SRAMEK, JJ
    SEIFERT, RD
    CONRAD, JJ
    WARDLE, TS
    DIES, F
    HURLEY, DJ
    THOREN, LM
    NEUROBIOLOGY OF AGING, 1994, 15 : S104 - S104
  • [8] Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects
    Bakker, Charlotte
    van der Aart, Jasper
    Labots, Geert
    Liptrot, Jan
    Cross, David M.
    Klaassen, Erica S.
    Dickinson, Steve
    Tasker, Tim
    Groeneveld, Geert Jan
    DRUGS IN R&D, 2021, 21 (03) : 295 - 304
  • [9] Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects
    Charlotte Bakker
    Jasper van der Aart
    Geert Labots
    Jan Liptrot
    David M. Cross
    Erica S. Klaassen
    Steve Dickinson
    Tim Tasker
    Geert Jan Groeneveld
    Drugs in R&D, 2021, 21 : 295 - 304
  • [10] XANOMELINE - A NOVEL MUSCARINIC RECEPTOR AGONIST WITH FUNCTIONAL SELECTIVITY FOR M(1) RECEPTORS
    SHANNON, HE
    BYMASTER, FP
    CALLIGARO, DO
    GREENWOOD, B
    MITCH, CH
    SAWYER, BD
    WARD, JS
    WONG, DT
    OLESEN, PH
    SHEARDOWN, MJ
    SWEDBERG, MDB
    SUZDAK, PD
    SAUERBERG, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (01): : 271 - 281
12345